Photo by Alex Shutin on Unsplash
Canada’s OTC & Pharma market, valued at approx. USD 28B in 2025, is projected to reach nearly USD 61B by 2030 at a CAGR of about 6.2%, driven by expanding pharmacy chains and changing consumer health trends.
Canada’s Consumer Health & Pharma Market Overview
Canada has one of the most developed healthcare markets in North America, supported by a strong public healthcare system and broad access to medical services overseen by Health Canada. As demographic trends and digital health adoption reshape how medicines are distributed and accessed, the country continues to offer stable growth opportunities for Consumer Health & Pharma companies.
Prescription medicines remain the primary revenue driver, particularly for chronic disease treatments, specialty therapies, and generics that support cost-efficient healthcare systems. Retail pharmacies alone dispensed over 855 million prescriptions, while generics accounted for 77.8% of prescriptions, reflecting the strong role of cost-effective treatments in the Canadian market.
The combined market for Rx and OTC products is projected to grow from approximately USD 28.73 billion in 2025 to nearly USD 45.88 billion by 2030, and could reach around USD 60.78 billion by 2040, reflecting a steady CAGR of about 6.17% (ex-factory prices) as healthcare demand and consumer health spending continue to rise.
Pharmacy Chains Dominating Canada’s Retail Landscape
Canada’s OTC & Pharma retail distribution is highly consolidated around large pharmacy chains & retailers which operate extensive store networks across the country. Major players include Shoppers Drug Mart (Loblaw Group), Costco, Jean Coutu, and Amazon, supported by numerous independent pharmacies and regional groups.
Pharmacy chains are also expanding their private-label consumer health portfolios, offering competitively priced OTC products, medical devices, and wellness products.
Figure 1: Canada Country Facts
Consumer Behaviour Trends in Canada’s Self-Medication Market
Consumer behaviour in Canada’s OTC market is evolving as healthcare becomes more consumer-driven. Several trends are shaping purchasing decisions and product demand:
- Growing self-medication culture: Consumers increasingly seek OTC solutions for minor health conditions, supported by pharmacist guidance.
- Digital health and e-commerce growth: Online pharmacies and omnichannel retail models are expanding rapidly.
- Demand for preventive healthcare: Vitamins, food supplements, and wellness products are gaining popularity among health-conscious consumers.
- Aging population: Older consumers drive demand for chronic disease management products and pharmacy services.
These shifts are reinforcing the importance of pharmacies as both healthcare providers and retail destinations.
Outlook for the Canadian OTC & Pharma Retail Market
Canada’s evolving Consumer Health & Pharma landscape offers significant opportunities for international companies seeking expansion in North America. The growing role of pharmacy chains, the increasing importance of preventive healthcare, and the rapid development of digital pharmacy channels are reshaping how OTC and Rx products reach patients and consumers.
For companies entering the Canadian market, success often depends on selecting the right local distribution partners, navigating regulatory requirements, and aligning product portfolios with consumer health trends such as self-medication, wellness products, and pharmacy-based healthcare services. Companies that successfully adapt to these dynamics will be best positioned to benefit from the steady growth of Canada’s OTC & Pharma sector and the expanding role of pharmacies as key healthcare access points.
Chameleon Pharma Consulting Group (CPC) has over 20 years of experience in supporting Pharma, OTC, Medical Devices, Phyto, and Aesthetic Medicine companies. Having established own offices & local hubs across Latin America, Europe, Asia, the US/Canada, the Middle East, and the CEE/CIS regions is another advantage of CPC. With this local network and expertise gained from 300+ international projects and a team of 25 experts we offer our clients:
- Business Development, M&A, and Due Diligence
- Market Entry & Expansion: Systematic product and country analysis, market reports
- Strategic Partnering: Identifying local partners, acquisitions, or setting up own offices
- Regulatory & Registration: for drugs, MD, Derma, Aesthetic Medicine, etc.
- Market Authorization & Compliance: Holding MAs, conducting pharmacovigilance
- Quality & Certification: GMP certification, pre-GMP audits
Contact us today for your individual request at service@chameleon-pharma.com!
